Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Beta Bionics (BBNX) Return on Equity (2024 - 2026)

Beta Bionics' Return on Equity history spans 3 years, with the latest figure at 0.0% for Q1 2026.

  • On a quarterly basis, Return on Equity rose 1.0% to 0.0% in Q1 2026 year-over-year; TTM through Mar 2026 was 0.0%, a 1.0% increase, with the full-year FY2025 number at 0.03%, down 3.0% from a year prior.
  • Return on Equity hit 0.0% in Q1 2026 for Beta Bionics, down from 0.0% in the prior quarter.
  • Over the last five years, Return on Equity for BBNX hit a ceiling of 0.0% in Q4 2024 and a floor of 0.01% in Q1 2025.
  • Historically, Return on Equity has averaged 0.0% across 3 years, with a median of 0.0% in 2025.
  • Biggest five-year swings in Return on Equity: changed 0bps in 2025 and later rose 1bps in 2026.
  • Tracing BBNX's Return on Equity over 3 years: stood at 0.0% in 2024, then crashed by -220bps to 0.0% in 2025, then dropped by -14bps to 0.0% in 2026.
  • Business Quant data shows Return on Equity for BBNX at 0.0% in Q1 2026, 0.0% in Q4 2025, and 0.0% in Q3 2025.